- Home
- SCNI vs BJDX Comparison
SCNI vs BJDX Comparison
Compare SCNI & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- BJDX
- Stock Information
- Founded
- SCNI 2003
- BJDX 2015
- Country
- SCNI Israel
- BJDX United States
- Employees
- SCNI N/A
- BJDX N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- BJDX Medical Specialities
- Sector
- SCNI Health Care
- BJDX Health Care
- Exchange
- SCNI Nasdaq
- BJDX Nasdaq
- Market Cap
- SCNI 2.0M
- BJDX 2.3M
- IPO Year
- SCNI N/A
- BJDX 2021
- Fundamental
- Price
- SCNI $1.52
- BJDX $1.40
- Analyst Decision
- SCNI
- BJDX
- Analyst Count
- SCNI 0
- BJDX 0
- Target Price
- SCNI N/A
- BJDX N/A
- AVG Volume (30 Days)
- SCNI 3.0M
- BJDX 35.3K
- Earning Date
- SCNI 08-19-2025
- BJDX 08-07-2025
- Dividend Yield
- SCNI N/A
- BJDX N/A
- EPS Growth
- SCNI N/A
- BJDX N/A
- EPS
- SCNI N/A
- BJDX N/A
- Revenue
- SCNI $658,000.00
- BJDX N/A
- Revenue This Year
- SCNI N/A
- BJDX N/A
- Revenue Next Year
- SCNI N/A
- BJDX $55.56
- P/E Ratio
- SCNI N/A
- BJDX N/A
- Revenue Growth
- SCNI N/A
- BJDX N/A
- 52 Week Low
- SCNI $1.40
- BJDX $1.38
- 52 Week High
- SCNI $6.18
- BJDX $20.00
- Technical
- Relative Strength Index (RSI)
- SCNI 29.96
- BJDX 33.26
- Support Level
- SCNI $1.40
- BJDX $1.46
- Resistance Level
- SCNI $1.64
- BJDX $1.55
- Average True Range (ATR)
- SCNI 0.24
- BJDX 0.06
- MACD
- SCNI -0.03
- BJDX -0.01
- Stochastic Oscillator
- SCNI 5.77
- BJDX 9.98
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.